Modified Pulsatilla decoction alleviates 5-fluorouracil-induced intestinal mucositis by modulating the TLR4/MyD88/NF-κB pathway and gut microbiota

Figure 3 Modified Pulsatilla decoction compounds ligand dock to the TLR4/MyD88/NF-κB pathway. A-E: Docking of glycyrrhizic acid with lipopolysaccharide lipopolysaccharide (LPS; A), TLR4 (B), MyD88 (C), TRAF6 (D), and NF-κB (E); F-J: Limonin with LPS (F), TLR4 (G), MyD88 (H), TRAF6 (I), and NF-κB (J).